An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurred in Wuhan, China, at the end of 2019. The World Health Organization named the resulting infectious disease as coronavirus disease-2019 (COVID-19). Many studies concluded that patients infected with SARS-CoV-2 have different degrees of liver disturbance. However, the relationship between the drugs used for COVID-19 treatment and liver disturbance remains controversial. It is essential to evaluate the potential liver damage caused by various drugs in order to help guide clinical practice. This review analyzed the effect of drugs on hepatic function during the treatment of COVID-19.
All Keywords
【저자키워드】 Treatment, severe acute respiratory syndrome coronavirus 2, Coronavirus disease 2019, drugs, liver disturbance, 【초록키워드】 COVID-19, SARS-CoV-2, coronavirus, drug, Infectious disease, outbreak, Patient, liver, Clinical practice, Liver damage, World Health Organization, acute respiratory syndrome, help, Wuhan, China, resulting, analyzed, evaluate, occurred, caused, hepatic function, infected with SARS-CoV-2, 【제목키워드】 COVID-19, disturbance,
【저자키워드】 Treatment, severe acute respiratory syndrome coronavirus 2, Coronavirus disease 2019, drugs, liver disturbance, 【초록키워드】 COVID-19, SARS-CoV-2, coronavirus, drug, Infectious disease, outbreak, Patient, liver, Clinical practice, Liver damage, World Health Organization, acute respiratory syndrome, help, Wuhan, China, resulting, analyzed, evaluate, occurred, caused, hepatic function, infected with SARS-CoV-2, 【제목키워드】 COVID-19, disturbance,